← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #860 OF 1,000 MOST-CITED

Verification activity - another entity, assess

FDA cited this observation 17 times across 17 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods17
BY FISCAL YEAR
FY20261
FY20251
FY20241
FY20234
FY20224
FY20214
FY20202

How FDA worded it — real examples

You did not document that you reviewed and assessed another entity's determination of the appropriate foreign supplier verification activities.

STC-NJ · Dripping Springs, Texas · Foods · 2026-02-05

You did not document that you reviewed and assessed another entity's determination of the appropriate foreign supplier verification activities.

Mediterranean Goods Inc · Alexandria, Virginia · Foods · 2025-04-03

You did not document that you reviewed and assessed another entity's determination of the appropriate foreign supplier verification activities.

SHRIJI MARKETING, LLC. · Lincoln Park, New Jersey · Foods · 2024-05-17

You did not document that you reviewed and assessed another entity's determination of the appropriate foreign supplier verification activities.

GCDMV LLC · Gaithersburg, Maryland · Foods · 2023-07-24

You did not document that you reviewed and assessed another entity's determination of the appropriate foreign supplier verification activities.

GLOBAL PREMIUM HARVEST · City Of Industry, California · Foods · 2023-07-14

You did not document that you reviewed and assessed another entity's determination of the appropriate foreign supplier verification activities.

Mayrsohn International Trading Co. Inc. · Miami, Florida · Foods · 2023-03-13

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Food industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →